Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
Micro Penny Stocks, Penny Stocks $0.10 & Under
»
CLBE watch for volume increase !! rumors flying
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is not enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by QuestSolver: [QB] E&E just released this!!! had a feeling the PR's release were related to our puppy!! LOL...look what E&E just put out for CLBE....I e-mailed Paul both the news reports you guys posted here!! [b]CalbaTech (OTC BB: CLBE): Why It Is Smart to Be Involved in Collection of Adult Stem Cells[/b] More Financial Analysis Say Adult Stem Cell Research Companies Better by Steven Ertelt LifeNews.com Editor August 9, 2006 New York, NY (LifeNews.com) -- More financial analysts are saying that biotech firms that work with adult stem cell research are better prospects for investors than those working with embryonic stem cells. The news comes after lobbyists and lawmakers condemned President Bush for focusing federal taxpayer dollars on adult stem cell research. Last week, LifeNews.com reported on one investment advisor who said companies relying on adult stem cells are more likely to provide payoffs for investors. "From a Wall Street perspective, adult stem cells are a much better investment," Stephen Dunn of Dawson James Securities, told CNN. "These are the guys who are going to be in the news in 2007 and 2008." "Adult stem cell research is advancing so far you might not need embryonic stem cells. If the federal government is reluctant to put their money into it, then Wall Street is as well." Dunn added. While embryonic stem cell research has seen numerous failures with animals and may be a decade or more away from producing any human therapies, adult stem cell research has already yielded dozens of treatments -- some of which may be at the market within years. The company is in the final stages of clinical trials and will soon be ready to submit the drug to the FDA in 2007. ***** Adult stem cell biotechs: better prospects, less controversy Several outfits are in the advanced stages of testing adult stem cells to help repair damaged bones as well as heart and breast tissue., By Aaron Smith, CNNMoney.com staff writer August 9 2006: 3:37 PM EDT NEW YORK (CNNMoney.com) -- Embryonic stem cells might hold the secrets to curing paralysis and brain damage, but they've also garnered plenty of controversy with the anti-abortion lobby because they're harvested from embryos. However, work using adult stem cells - which are donated by grown men and women - is not only free of such controversy, it's actually much closer to getting effective products on the market. Work with adult stem cells isn't being held back by funding restraints and political opposition, analysts say. "Embryonic stem cell research hasn't kept up pace with adult stem cell research," said Dunn. "Adult stem cell research is advancing so far you might not need embryonic stem cells. If the federal government is reluctant to put their money into it, then Wall Street is as well." So while embryonic stem cell researchers are experimenting with rats, adult stem cell researchers have moved on to more advanced tests with humans. The embryonic-based stem cell treatments are probably a decade away, but the U.S. market could see its first adult-based stem cell treatments within the next couple of years. [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2